(Alliance News) - Shares in ECO Animal Health Group PLC were down on Monday, as the company said it expects to pay a GBP2.5 million tax settlement. Read More
ECO Animal Health Group - Surrey-based pet and livestock pharmaceuticals - Signs new bank facility agreement with its bank, National Westminster Bank PLC. The new facility is a revolving banking facility and will provide for drawings of up to GBP10 million in flexible amounts and repayment periods. The facility has a term expiring on June 30, 2026, and the interest rate is 1.95% plus the sterling overnight index average lending rate. Read More
ECO Animal Health Group PLC - Surrey-based pet and livestock pharmaceuticals - Enters research partnership with Moredun Research Institute, where both parties will work to develop a vaccine for the control of poultry red mite. Read More
ECO Animal Health Group PLC - Surrey-based pet and livestock pharmaceuticals - Says its subsidiary ECO Animal Health Ltd has entered into a research partnership with Robin Shattock at Imperial College London to assess saRNA technology. ECO says the collaboration will be the delivery of vaccine antigens and biologics to pigs against three important infectious disease targets. Read More
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and not separately reported by Alliance News: Read More
ECO Animal Health Group PLC - Surrey-based pet and livestock pharmaceuticals - Chief Financial Officer Christopher Wilks buys 50,000 shares at 140 pence each, worth GBP70,000, on Friday last week. Now has 74,095 shares. Read More
ECO Animal Health Group PLC - Surrey, England-based pet and livestock pharmaceuticals - Confirms that it continues to trade in line with its revised revenue and margin expectations. Notes that this is despite difficult trading conditions due to "volatile" pork prices and "cautious" producers. Read More
ECO Animal Health Group PLC - Surrey, England-based pet and livestock pharmaceuticals - Says it received two marketing authorisations from the Ministry of Agriculture and Rural Affairs in China for the use of Aivlosin water-soluble granules. Read More
